Movatterモバイル変換


[0]ホーム

URL:


GB0820819D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0820819D0
GB0820819D0GBGB0820819.1AGB0820819AGB0820819D0GB 0820819 D0GB0820819 D0GB 0820819D0GB 0820819 AGB0820819 AGB 0820819AGB 0820819 D0GB0820819 D0GB 0820819D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0820819.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sareum Ltd
Original Assignee
Sareum Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sareum LtdfiledCriticalSareum Ltd
Priority to GBGB0820819.1ApriorityCriticalpatent/GB0820819D0/en
Publication of GB0820819D0publicationCriticalpatent/GB0820819D0/en
Priority to PCT/GB2009/002662prioritypatent/WO2010055304A2/en
Ceasedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

GBGB0820819.1A2008-11-132008-11-13Pharmaceutical compoundsCeasedGB0820819D0 (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
GBGB0820819.1AGB0820819D0 (en)2008-11-132008-11-13Pharmaceutical compounds
PCT/GB2009/002662WO2010055304A2 (en)2008-11-132009-11-13Pharmaceutical compounds

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GBGB0820819.1AGB0820819D0 (en)2008-11-132008-11-13Pharmaceutical compounds

Publications (1)

Publication NumberPublication Date
GB0820819D0true GB0820819D0 (en)2008-12-24

Family

ID=40194606

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GBGB0820819.1ACeasedGB0820819D0 (en)2008-11-132008-11-13Pharmaceutical compounds

Country Status (2)

CountryLink
GB (1)GB0820819D0 (en)
WO (1)WO2010055304A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP2250160B1 (en)2008-01-252015-11-11Millennium Pharmaceuticals, Inc.Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
US9090601B2 (en)2009-01-302015-07-28Millennium Pharmaceuticals, Inc.Thiazole derivatives
WO2010090716A1 (en)2009-01-302010-08-12Millennium Pharmaceuticals, Inc.Heteroaryls and their use as pi3k inhibitors
US8796314B2 (en)2009-01-302014-08-05Millennium Pharmaceuticals, Inc.Heteroaryls and uses thereof
US9062038B2 (en)2010-08-112015-06-23Millennium Pharmaceuticals, Inc.Heteroaryls and uses thereof
JP2013533318A (en)2010-08-112013-08-22ミレニアム ファーマシューティカルズ, インコーポレイテッド Heteroaryl and uses thereof
KR20130098334A (en)2010-08-112013-09-04밀레니엄 파머슈티컬스 인코퍼레이티드 Heteroaryls and uses thereof
US8765746B2 (en)2010-10-132014-07-01Millennium Pharmaceuticals, Inc.Heteroaryls and uses thereof
WO2012075393A2 (en)*2010-12-022012-06-07President And Fellows Of Harvard CollegeActivators of proteasomal degradation and uses thereof
GB201202027D0 (en)*2012-02-062012-03-21Sareum LtdPharmaceutical compounds
EP3040336B1 (en)2012-03-022020-04-08Sareum LimitedCompounds for use in treating tyk2 kinase mediated conditions
JP6348492B2 (en)*2012-08-102018-06-27ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Heteroaromatic compounds as breton-type tyrosine kinase (BTK) inhibitors
CN103848810A (en)*2012-11-302014-06-11北京赛林泰医药技术有限公司Bruton's tyrosine kinases inhibitor
WO2014151620A1 (en)2013-03-142014-09-25Boehringer Ingelheim International Gmbh5-thiazolecarboxamide dervatives and their use as btk inhibitors
WO2014152114A1 (en)2013-03-152014-09-25Boehringer Ingelheim International GmbhHeteroaromatic compounds as btk inhibitors
KR102191084B1 (en)*2013-09-032020-12-15사름 리미티드Pharmaceutical compounds
SI3052476T1 (en)2013-09-302020-12-31Guangzhou Innocare Pharma Tech Co., Ltd.Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
US9828364B2 (en)2014-01-292017-11-28Boehringer Ingelheim International GmbhPyrazole compounds as BTK inhibitors
WO2016077163A1 (en)*2014-11-112016-05-19Musc Foundation For Research DevelopmentHistone deacetylase inhibitors and uses thereof
CN108368086B (en)2015-12-162021-01-08勃林格殷格翰国际有限公司Dipyrazolyl derivatives useful in the treatment of autoimmune diseases
EP3402789B1 (en)2016-01-132020-03-18Boehringer Ingelheim International GmbhIsoquinolones as btk inhibitors
GB201617871D0 (en)2016-10-212016-12-07Sareum LimitedPharmaceutical compounds
GB201816369D0 (en)2018-10-082018-11-28Sareum LtdPharmaceutical compounds
KR20220002488A (en)2019-04-302022-01-06셀진 코포레이션 Combination therapy comprising apremilast and a TYK2 inhibitor
GB202005114D0 (en)2020-04-072020-05-20Sareum LtdCrystalline Forms of a Pharmaceutical Compound
US20240287052A1 (en)*2021-06-012024-08-29Azcuris Co., Ltd.Novel oxazole derivative and pharmaceutical composition for preventing or treating allergic diseases comprising the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JPS61155456A (en)1984-12-271986-07-15Fujikura Rubber LtdElectromagnetic wave shielding composition
JPH0753716B2 (en)1986-07-021995-06-07吉富製薬株式会社 Imidazol carboxamide derivative
WO2002000649A1 (en)2000-06-282002-01-03Astrazeneca AbSubstituted quinazoline derivatives and their use as inhibitors
US6884889B2 (en)2002-03-252005-04-26Bristol-Myers Squibb Co.Processes for the preparation of antiviral 7-azaindole derivatives
CA2491895C (en)2002-07-092011-01-18Vertex Pharmaceuticals IncorporatedInhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
EP1620406A2 (en)*2003-05-082006-02-01Astellas Pharma Inc.1,2-diarylimidazoles useful as inhibitors of cox
GB0321648D0 (en)2003-09-162003-10-15Astrazeneca AbQuinazoline derivatives
EP1684750B1 (en)2003-10-232010-04-28AB Science2-aminoaryloxazole compounds as tyrosine kinase inhibitors
JP2008517060A (en)2004-10-192008-05-22エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド CRF receptor antagonist and process for producing the same
GB0504753D0 (en)2005-03-082005-04-13Astrazeneca AbChemical compounds
JPWO2007043401A1 (en)2005-10-072009-04-16キッセイ薬品工業株式会社 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
DE602007009085D1 (en)2006-05-122010-10-21Ab Science NEW PROCEDURE FOR SYNTHESIS OF 2-AMINO-OXAZO COMPOUNDS
WO2008024980A2 (en)2006-08-242008-02-28Serenex, Inc.Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives
GB0709031D0 (en)*2007-05-102007-06-20Sareum LtdPharmaceutical compounds

Also Published As

Publication numberPublication date
WO2010055304A3 (en)2010-07-08
WO2010055304A2 (en)2010-05-20

Similar Documents

PublicationPublication DateTitle
ZA201104336B (en)Pharmaceutical compounds
GB0816372D0 (en)Pharmaceutical compounds
GB0820819D0 (en)Pharmaceutical compounds
GB0801416D0 (en)Pharmaceutical compounds
IL237392A0 (en)Pharmaceutical combination
GB0709031D0 (en)Pharmaceutical compounds
IL201366A0 (en)Pharmaceutical compounds
GB0721095D0 (en)Pharmaceutical compounds
GB0816371D0 (en)Pharmaceutical compounds
GB0707087D0 (en)Pharmaceutical compounds
GB0810615D0 (en)Novel pharmaceutical
GB0704932D0 (en)Pharmaceutical compounds
GB0725214D0 (en)Pharmaceutical compounds
GB0812969D0 (en)Pharmaceutical compounds
PL2271618T3 (en)Pharmaceutical compounds
GB0816370D0 (en)Pharmaceutical compounds
GB0721669D0 (en)Pharmaceutical compounds
IL208953A0 (en)Pharmaceutical combination
GB0810857D0 (en)Pharmaceutical compounds
GB0810617D0 (en)Novel pharmaceutical
HU0800414D0 (en)Pharmaceutical combination
GB0817006D0 (en)Pharmaceutical compounds
GB0805300D0 (en)Pharmaceutical compounds
GB0802252D0 (en)Pharmaceutical compounds
GB0807502D0 (en)Pharmaceutical compounds

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)

[8]ページ先頭

©2009-2025 Movatter.jp